First human tests for new hay fever drug
NCT ID NCT06038279
Summary
This early-stage study tested the safety of a new drug called INI-2004 for people with ragweed allergies (hay fever). First, healthy volunteers received single doses. Then, people with confirmed ragweed allergies received multiple weekly doses. The main goal was to check for side effects and see how the body processes the drug, while also measuring if it helped reduce allergy symptoms like sneezing and congestion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Pty Ltd
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.